» Articles » PMID: 6479019

Some Pitfalls in Selecting Descriptive Pharmacokinetic Models

Overview
Specialties Pharmacology
Pharmacy
Date 1984 Sep 1
PMID 6479019
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Some pitfalls in selecting pharmacokinetic models are enumerated. To calculate the pharmacokinetic parameters of a drug that exhibits a biphasic convex plasma concentration-time curve, a two-compartment model does not automatically have to be applied. When only the parent drug in plasma is considered, a two-compartment model seems to be most appropriate. However, when the kinetic behavior of the metabolite has to be taken into account, and when a metabolic equilibrium underlies the metabolic elimination, the two-compartment model may not be appropriate. Also, when calculating the kinetic parameters of a drug with a concave biphasic plasma concentration-time curve, a capacity-limited metabolic conversion is not the automatic explanation for this observation. Limitations in renal excretion and bioavailability may be the reasons for this behavior. Convex and concave biphasic plasma concentration-time curves are illustrated, using sulfonamides as test compounds.

Citing Articles

Clinical pharmacokinetics of dapsone.

Zuidema J, Merkus F Clin Pharmacokinet. 1986; 11(4):299-315.

PMID: 3530584 DOI: 10.2165/00003088-198611040-00003.


Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

Kauffman R, Kearns G Clin Pharmacokinet. 1992; 23(1):10-29.

PMID: 1617856 DOI: 10.2165/00003088-199223010-00002.